Medtronic plc (MDT) Earnings Call Analysis

NYSE · Healthcare · Medical Devices

25/25

Growth 5 Margin 5 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

25
Medtronic (MDT) Q1 2027: 13.7% Organic Growth Driven by Broad-Based Innovation and Strategic Investments
September 01, 2026
24
Medtronic (MDT) Q4 2026: CAS Revenue Surges 78%, Fueling Durable Innovation-Led Growth
June 03, 2026
22
Medtronic (MDT) Q3 2026: Cardiovascular Jumps 11%, Pipeline Broadens Margin Pathways
February 23, 2026
24
Medtronic (MDT) Q2 2026: Cardiac Ablation Grows 71%, Igniting Multi-Year Revenue Acceleration
November 18, 2025
22
Medtronic (MDT) Q1 2026: Cardiac Ablation Solutions Surge 50%, Setting Up Multi-Year Growth Cycle
August 19, 2025
25
Medtronic (MDT) Q4 2025: Diabetes Spin-Off and Durable Growth Reshape Portfolio for Higher Margins
June 10, 2025

Browse all companies